These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11893839

  • 1. Cognitive deficits and polymorphism of apolipoprotein E in Alzheimer's disease.
    Luczywek E, Nowicka A, Pfeffer A, Czyzewski K, Styczyńska M, Lałowski M, Barcikowska M.
    Dement Geriatr Cogn Disord; 2002; 13(3):171-7. PubMed ID: 11893839
    [Abstract] [Full Text] [Related]

  • 2. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E, Pffefer A, Nowicka A, Czyzewski K, ŁaŁowski M, Styczyńska M, Barcikowska M.
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [Abstract] [Full Text] [Related]

  • 3. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 4. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [Abstract] [Full Text] [Related]

  • 5. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano FD, Brahe C, Masullo C.
    Dement Geriatr Cogn Disord; 2005 Jun; 20(4):254-61. PubMed ID: 16103669
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
    Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Mullan M, Duara R.
    Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC, Gatzima O, Daniilidou M, Lazarou E, Bamidis PD, Verykouki E, Iakovidou-Kritsi Z, Tsolaki M.
    Neurodegener Dis; 2018 Sep; 18(4):216-224. PubMed ID: 30205398
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A.
    Dement Geriatr Cogn Disord; 2007 Sep; 23(5):327-33. PubMed ID: 17374951
    [Abstract] [Full Text] [Related]

  • 12. Impact of APOE in mild cognitive impairment.
    Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC.
    Neurology; 2004 Nov 23; 63(10):1898-901. PubMed ID: 15557508
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P, Calvo C, Albala C, Urquidi J, Santos JL, Pérez H, Klaassen G.
    Neuroepidemiology; 1999 Nov 23; 18(1):48-52. PubMed ID: 9831815
    [Abstract] [Full Text] [Related]

  • 14. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM, Clarnette RM, Taddei K, Martins G, Paton A, Hallmayer J, Almeida OP, Groth DM, Gandy SE, Förstl H, Martins RN.
    Mol Psychiatry; 2002 Nov 23; 7(7):768-75. PubMed ID: 12192621
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.
    Dement Geriatr Cogn Disord; 2004 Nov 23; 18(2):125-31. PubMed ID: 15211066
    [Abstract] [Full Text] [Related]

  • 16. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ, Lucas JA, Rippeth JD, Bohac DL, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR.
    J Int Neuropsychol Soc; 2003 Jul 23; 9(5):751-9. PubMed ID: 12901781
    [Abstract] [Full Text] [Related]

  • 17. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.
    Rev Neurol; 2003 Jul 23; 38(9):801-7. PubMed ID: 15152345
    [Abstract] [Full Text] [Related]

  • 18. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Jul 23; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.
    Hirono N, Hashimoto M, Yasuda M, Kazui H, Mori E.
    J Neuropsychiatry Clin Neurosci; 2003 Jul 23; 15(3):354-8. PubMed ID: 12928512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.